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Abstract
Background: This is the first investigation of its kind to explore the views of people affected by
pancreatic cancer with regard to research priorities. Pancreatic cancer has an extremely poor
outlook in terms of early diagnosis, effective treatment and survival. Those affected by the disease
generally lack opportunities to voice their needs or concerns in an organised manner, link with
others affected by the condition and take part in research.
Methods:  This qualitative study adopts a self-selected telephone focussed discussion group
approach. Information was obtained from distinct carer and patient groups after adequate controls
such as the 'safe space' technique (repeatedly enquiring on and respecting the emotional needs)
were implemented to protect participants from undue physical and psychological distress.
Results: Five themes emerged overall, with three themes being common between the patients and
carers groups. Early detection, clinician communication and public awareness were areas of
recurring discussion and consensus for both groups. The fourth theme to emerge for the patient
group centred on quality of care, while the fourth theme of the carer group focused on the need
for more and improved treatment options.
Conclusion: Research priorities for pancreatic cancer consumers have been identified via an
investigation that was tailored to meet exceptional needs. This research gives us a primary
understanding of the role that pancreatic cancer patients can play in identifying areas of research
that are responsive to their needs and priorities when suitably planned. Importantly it also provides
a much greater understanding of the grim realities of the disease for those affected. This work is
likely to be of value to anyone planning to work with those with a time limited, challenging
condition.
Background
Pancreatic cancer (PC) is a deadly disease. The early vague
symptoms are easily overlooked and high-risk delays in
diagnosis are very common. Only around 10% of patients
are considered for surgical treatment [1]. PC is the fourth
leading cause of death in Western societies and recently
the national rate of new cases in Australia has increased by
30% [2]. The ageing of the Australian population means
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that a proportionate increase in the number of people
affected by PC, including carers, can be expected. Cur-
rently, few formal protocols exist for best clinical practice
in PC management and no multidisciplinary care teams
are reported [3].
There has been little improvement in the 5 year PC sur-
vival rate over the last few decades which have remained
extremely low at around 5% with the majority of patients
(~90%) dying within a year of diagnosis [4]. This com-
pares very poorly with relative 5 year survival rates for
more common malignancies such as melanoma, breast
and prostate cancer which are greater than 80%, and for
all cancers combined (65%) [5]. Contributing to this
unfortunate situation is the long-standing relative lack of
scientific knowledge of the disease; including research in
all aspects, from aetiology through to effective palliative
care, and an understanding of how those affected endure
in daily life.
Research can lead to new or advances in treatment,
improved life expectancy, better quality of life, reduced
social burden and a wide range of other potential benefits.
Until recently, the Australian scientific community, who
largely determine priorities for cancer research, had not
often selected PC. Dedicated funding programs targeting
this cancer and other understudied human diseases have
now been developed by a key government research fund-
ing body to encourage a more balanced approach in the
spread of research across different diseases with the goal
of reducing occurrence, morbidity and adverse outcomes
[6].
Cancer Council NSW (CCNSW) is NSW's largest publicly
funded cancer charity, which supports a significant pro-
portion of Australia's cancer research. In 2006, one of the
research grant schemes of CCNSW, the Strategic Research
Partnership Grant [7], founded a network of key PC
researchers and consumers affected by PC. An important
function of the NSW Pancreatic Cancer Network [8] has
been to systematically define critical research issues and
opportunities that could accelerate progress in PC
research in Australia. The rigorous prioritisation process
began with a literature review, followed by structured
interviews with key opinion leaders in the field, whose
recommendations were then fed into a Delphi consensus
process. The recommendations from the Delphi and dis-
crete consumer involvement processes were ultimately
prioritised via a nominal group procedure.
The aim of this paper is to describe the technique used to
capture consumer priorities in PC research, together with
the findings of the investigation. Consumers are recog-
nised as patients and carers of people diagnosed with PC.
Cancer research is a matter of great public interest in NSW
[9] and it is very important to CCNSW that both research-
ers and consumers are involved in research decision mak-
ing processes [10], as failure to involve the community is
likely to result in important areas of inquiry not being rec-
ognised. Involving consumers in research prioritisation is
still a novel process both in Australia and in other coun-
tries, and seeking consumer views on research priorities in
PC presents additional challenges, as diagnosis at an
advanced stage, rapid disease progression and overt symp-
toms, including pain, limits the applicability of tradi-
tional methods of consumer consultation.
Currently the academic literature tells us that consumers
have had dialogue with research funders about research
priorities/gaps, they have been involved in the priority
ranking of pre-established research questions and as
members on committees they have collaborated with sci-
entists to prioritise research across a range of health topics
including breast cancer, mental health, physical and com-
plex disabilities, young people, cystic fibrosis and HIV
[11-13]. Although less common, consumers have also
independently identified issues and set research agendas
for specific cancer types [14], nevertheless we have been
unable to identify any inquiries that provide those
affected by pancreatic cancer the opportunity to interact,
discuss and identify research priorities that are important
to them.
Methods
This study was designed in consultation with a key stake-
holder group comprising pancreatic cancer researchers,
consumers and representatives of CCNSW. The Concord
Hospital Human Research Ethics Committee (NSW, Aus-
tralia) approved the research. Informed consent was
gained from all research participants.
Self-selected participants were recruited from CCNSW
website and newsletter information which described the
opportunities and benefits of involvement in a newly
launched CCNSW Pancreatic Cancer Support Project which
was established to identify and address unmet supportive
care needs of PC patients, and current or bereaved carers.
Consumers opting into the Project were informed of the
opportunity and invited to take part in a focused discus-
sion to identify pancreatic cancer research priorities. Vol-
untary and informed consent to participate in the research
was gained after all relevant information was provided
and interested persons assured us they had adequate
understanding of the study requirements.
Participants were given the option of a traditional face-to-
face discussion or one conducted by telephone, with tele-
phone delivered focussed discussion the preferred option.BMC Research Notes 2009, 2:179 http://www.biomedcentral.com/1756-0500/2/179
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One discussion group comprised patients with a PC diag-
nosis while another involved current and bereaved carers
of PC patients. Separating the groups allowed for focussed
discussion on issues that particularly affected each group.
Other investigators have used teleconference focussed dis-
cussions as the major/sole way to collect data, primarily to
overcome distance and participant particular needs, and
found them to be successful [15-17]. The limitations high-
lighted in these studies such as the increased difficulty in
controlling participants using the phone method were
taken into account in the design of the current study.
The focussed discussion method was selected so we could
examine not only what PC consumers thought, but also
why they thought it via comparing and contrasting per-
sonal experiences and perspectives in group discussion.
The basic assumption of this interpretive approach was
that relevant information would be gained through inter-
action with others, shared meanings and conclusions.
As the research involved gaining an in-depth understand-
ing of issues, including an exploration of the reasons and
context for participants' viewpoints and actions, the facil-
itators agreed on a 'safe space' approach prior to the focus
groups. This approach of repeatedly enquiring on and
respecting the emotional needs of participants allowed
them to openly disclose (and acknowledge in others)
emotional and/or physical distress without fear of dis-
rupting the discussion, particularly when the dialogue
centred on suffering and/or death [18,19].
The facilitated discussions were audiotaped and subse-
quently transcribed. Two CCNSW telephone support
group counsellors, one acting as moderator; an independ-
ent qualitative researcher, and the Project coordinator, as
subject expert, facilitated the group discussions. All partic-
ipants were provided with the purpose and ground rules,
and were assured of the confidential nature of the infor-
mation gathered during the discussions. The moderator
also explained the need for audio-recording the discus-
sion for analysis purposes.
At the commencement of the focussed discussions partic-
ipants in each group were asked the question: Where would
you like to see progress in pancreatic cancer being made? After
participants raised and discussed each issue they felt was
important to the topic, the facilitator fed the main points
back to confirm the interpretation of comments and to
reach agreement on the main themes of the discussion.
Before ending each group discussion by formally thanking
participants, the moderator provided participants with
information on the cost free CCNSW professional tele-
phone support services to provide them with an ongoing
avenue to speak about their experiences and concerns in
the future.
Data analysis
A thematic content analysis was manually conducted with
pattern recognition within the data identified after careful
listening to the audiotape and reading/re-reading the tran-
scripts by two researchers (CS and MR) independently.
Acknowledging the context and participants of the
research, repeating issues were identified and clustered,
and subsequently developed into focal themes.
Results
Demographics
Twelve people responded to the invitation to participate
in the study with eleven taking part after ill health pre-
vented the participation of one male. Five current and
bereaved carers made up one group, with one bereaved
carer providing email responses to the questions raised
with the group. Six people diagnosed with PC took part in
the other phone group discussion. Table 1 provides the
demographic characteristics of the research participants.
Identified themes
The carers and patients discussion groups each lasted
approximately one hour. For the most part, discussion
was based on personal experiences rather than opinion or
conjecture. The audiotapes provided an understanding of
the tone of conversations and the levels of urgency partic-
ular topics produced. Overall, participants in each group
verbally expressed a range of emotions throughout the
session from anger and frustration to grief. Most were
active information providers and many expressed consid-
erable worry. In general, there was no area of discussion in
which each group of participants failed to reach general
consensus.
Table 1: Demographic Characteristics of the Research 
Participants
Focus Groups (n = 11)
1 (patients) 2 (carers)
Gender
Male 1 1
Female 5 4
Age ranges (years)
Male 70-79 60-69
Female 30-59 30-49
Place of Residence
Urban 4 4
Regional/rural 1 1
Unknown 1BMC Research Notes 2009, 2:179 http://www.biomedcentral.com/1756-0500/2/179
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Five themes emerged overall, with three being common
between the patients and carers groups. Early detection,
clinician communication and public awareness were areas
of recurring discussion and consensus for both groups.
The fourth theme to emerge for the patient group centred
on quality of care, while the fourth theme of the carer
group focused on the need for more and improved treat-
ment options.
Tables 2 and 3 provide a complete overview of the identi-
fied focal themes and the repeated issues from which they
were derived for each group.
Early Detection
All participants appeared to have a well-developed under-
standing of the lack of current knowledge with regard to
the causes of pancreatic cancer and the important benefits
of early cancer detection. Many expressed concern for the
urgent need for improvements in the early detection and
formal diagnosis of pancreatic cancer not only for them-
selves or their loved ones, but for others who may develop
the disease in the future:
"I would like to see some work done in the area of symptoms
and diagnostic tools so people who have got a problem can
hopefully get a quicker result"
Some pointed out their low personal health locus of con-
trol with regard to detecting pancreatic cancer:
"I found out when it was too late because I had no symp-
toms to indicate a tumour of the pancreas "
Others offered ways that research might find solutions to
the problem of asymptomatic early detection:
"I was given to understand that all cancers...are a genetic
failure of some sort. A mistake is multiplied on and on and
gets out of control. It's like the body has a spell-check sys-
tem, putting it very simply. A word can be spelt wrong but
it's still a word and it's not identified. Is there any way of
looking at the body's spell-check system to see if there are
any mistakes there that haven't been detected?"
Clinician Communication
All participants verbally expressed some alarm, many with
an underlying tone of disbelief, in the insensitive nature
of dialogue used by the clinicians in the provision of the
pancreatic cancer diagnosis and/or management options.
"I hate him for what he said .....5 o'clock on a Friday night
I'm a healthy person, I'm lively, I had a life planned to 95,
and he (doctor) told me I would be dead in six to 18
months. I was stunned......"
Some felt it was extremely important to be allowed to
express their own perceptions of their illness; however
their clinicians had not provided this opportunity:
"Anything we mentioned was virtually cast aside, almost
contemptuously... The prognosis may be dismal, but my
wife was entitled to a lot more than that. The human spirit
demands more than that"
One carer came to the defence of medical specialists and
offered a solution to the problem:
"That conversation regarding pancreatic cancer is never
going to be a nice one and we have to avoid shooting the
messenger there. Maybe there could be some protocol that
specialists follow a little more thoroughly"
There was general agreement in both the carer and patient
groups for the pressing need for health professional com-
munication guidelines which take into account the sensi-
tivity of the individual affected by pancreatic cancer.
Public Awareness
Overall there was low confidence in the ability of availa-
ble public information to provide all that was needed by
people affected by PC.
" see a priority in education/awareness of pancreatic cancer
because I've spoken to people who don't even know what it
is or where it is"
Particular concerns with regard to public awareness of
pancreatic cancer differed somewhat between the patient
and carer groups. Patients highlighted the need for relia-
ble information on effective treatments:
"Some people might even decide to go overseas for treat-
ment and to try different things. So information is very
important. There are many other alternatives and some of
them may not be cheap"
One patient believed their illness was not taken as serious
as it should have been by others in the community
because of a lack of general awareness. Other patients felt
that the available information on PC needed to be made
more easily accessible than it currently was:
"We need a central information point, whether its written
literature or whatever, that can be referred to immediately"
There was general consensus among carers for the need for
public information that had the potential to save lives in
the future:BMC Research Notes 2009, 2:179 http://www.biomedcentral.com/1756-0500/2/179
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Table 2: Pancreatic cancer patients repeated issues and focal themes
Recurring issue Focal theme
"I would like to see some work done in the area of symptoms and diagnostic tools so people who have got a problem can hopefully 
get a quicker result"
"People that have had gallstones and have had their gall bladder out, and 18 months later it's been diagnosed as pancreatic cancer. 
So it's those sorts of correlations and the diagnostic tools need to be fine-tuned"
"I agree with you ... I had to have a battery of tests to sort mine out, basically because I was pretty sick at the time. I would like to 
see the testing simplified a bit. I was sick for a couple of months before, but I had to be sick enough to be in hospital before it was 
found"
"Cancer is the silent killer. By the time I was diagnosed it was too late. "Mine had already moved over to the liver and the spleen and 
so there was no surgery involved because there were too many organs"
"Early diagnosis would be ideal. I found out when it was too late....
"People need to get to the doctor before it's too late so they can have options"
Early detection
"I first heard of my pancreatic cancer on 18 July when I first went in to see the doctor. He sent me straight for an MRI. I hate him 
for what he said when I came back five hours later: 5 o'clock on a Friday night I'm a healthy person, I'm lively, I had a life planned 
to 95, and he told me I would be dead in six to 18 months. I was stunned...... I think what I would like to say here is we must have 
information presented in a professional form"
"While treatment is happening and I get side effects, the nurses never clarify that it is a side effect. They just send me to my GP and 
unfortunately my GP is very much like your GP -- I don't get a lot of information. He needs correct information about side effects of 
different types of treatment and there was nothing"
"Regarding my diagnosis, I believe strongly that the doctor should have been able to refer me, or the next lot of people that it 
happens to, to a counsellor or to someone who will actually give you a cup of tea for a start. The diagnosis should not be delivered 
to people like it was to me. "If you were sick for a period of time, you could expect something like that, but it was like delivering a 
life sentence when you hadn't murdered anyone and weren't on trial"
"I (also) believe that anybody who has been diagnosed with cancer should have their next appointment, as soon as possible, with a 
counsellor"
"As well as the diagnosis, I was just hit with - you know when you find pancreatic cancer it's usually too late and there's not much 
that can be done about it. That seemed to be the general attitude. I was in hospital at the time and it just seemed to be the attitude 
amongst all medical professions, right down from the intern to the specialists"
"Some people want to take part in trials as they want the latest in treatment. Could that be part of an information package with 
regard to options?"
"I came away and, even in the horror of things, I said to my friend that he sounds like a very good used car salesman. So he offered 
me one (chemo option) with another three. I asked him what if and he quickly gave me a very short spiel of the risks attached"
Clinical communication
"When someone says they have this cure and I say "yes, but it's only for breast or bowel cancer", which is nothing compared to what 
I have.... "We need the information out there that it is advanced, unique and aggressive.... I agree with general community 
awareness because people need to know. I didn't know that the pancreas was so important...."
"We need a central information point, whether its written literature or whatever, that can be referred to immediately"
"Some people might even decide to go overseas for treatment and to try different things. So information is very important. There are 
many other alternatives and some of them may not be cheap"
"Maybe if people knew what some of the symptoms were, like ovarian cancer, they would go and get checked"
"The other suggestion is the immediate sharing of information. You hear something and you would like to assist and support that 
person....... I would be only too happy to volunteer my time for so many hours a week to help with that if I could"
Public awareness
"A few of us have had the Whipple procedure, but there are variations within the procedure itself. I know that most progress has 
been made in America and I'm sure there are various good reasons why there are delays in getting that information here. I wonder 
whether we can speed up that process or have our surgeons trained more quickly"
"It sounds awful but it sometimes does seem to be the quality of your GP that gets the results quicker too and some of the medical 
profession not even knowing, so there's a lack of awareness as well"
"I went to the doctor last week and I couldn't get in to see my regular doctor so I just saw one at the local medical centre. I told him 
I had had a Whipple procedure. He had never heard of a Whipple procedure and this is a doctor"
"There seems to be a lack of awareness with GPs and also specialists even just knowing about enzymes. Some people say their 
doctor has never mentioned it, and I've spoken to a few people who have had a Whipple procedure"
"My naturopath mentioned enzymes so I'm taking a supplement. That's what I was saying before -- it's either lack of information or 
people just say to keep eating normally, which is not the right thing to do because everyone is different and people react differently 
to different foods"
"At no time was I given an option. I have heard from other people that there are different types of medication that may be more 
costly; however, they were never given the choice to decide to pay for the cost of more expensive medication....... I think it's up to the 
cancer patient to make a decision as to which treatment is more suitable for them and whether they have the means to pay for 
more expensive drugs not covered by Medicare or a private fund"
"I believe that we need a coordinated group of people who are, say, oncologists and surgeons and radical people and alternatives"
Quality of careBMC Research Notes 2009, 2:179 http://www.biomedcentral.com/1756-0500/2/179
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"People have got to know what pancreatic cancer is and
what some of the symptoms are, and I think we all acknowl-
edge they are very vague, but the sharpening of that focus
on "this could be" or "you need to". It's only when we know
about something that we'll follow up on it"
Quality of Care
The patient group was united in their thinking on the
need for improvements in the standard and consistency of
clinical care and understanding of PC:
"A few of us have had the Whipple procedure, but there are
variations within the procedure itself. I know that most
progress has been made in America and I'm sure there are
various good reasons why there are delays in getting that
information here. I wonder whether we can speed up that
process or have our surgeons trained more quickly"
Health professional team coordination was also identified
as being important:
"I believe that we need a coordinated group of people who
are, say, oncologists and surgeons and radical people and
alternatives"
Treatment Options
Carers voiced the need for improved and additional treat-
ment options for PC:
"I know everything is hypothetical, but you have your oper-
ation and go through all of that, but there are really not
enough options for you to make decisions about what you
will or won't do"
Table 3: Carers repeated issues and focal themes
Recurring issue Focal theme
"With the diagnosis, I wish there was some sort of way they could have done it more quickly"
"From my wife's experience, it was 12 months or even longer.... We were backwards and forwards to doctors. It was only in the 
latter stages that it was diagnosed"
"From my experience as well, that it was the detection ... and the diagnosis which was delayed which meant the disease had 
progressed"
"I can only echo what the others have said. The issue, certainly in my mother's case, was no detection... it was only when the cancer 
had spread"
"It just seems that early detection is the really only useful thing that can help in saving lives"
"I totally agree with everything that everyone has said today. Early detection.... if that can all be brought in to help other people"
Early detection
"When the actual first diagnosis was given to us, we had an unfortunate experience as it was rather brutal. My wife was told to get 
her affairs in order. That's not treating the individual as a whole person. We just felt very badly let down"
"I didn't feel that the manner of delivery was particularly warm. It's almost like some of the specialists are so experienced with what 
they're doing that they lose sight of the fact that for the person who's been diagnosed, it's the first time they've ever heard these 
words. Very often what's been told is there is actually nothing that can be done. Maybe there could be a set of words and 
communication could be improved a little bit?"
"Anything we mentioned was virtually cast aside, almost contemptuously... The prognosis may be dismal, but my wife was entitled to 
a lot more than that. The human spirit demands more than that"
"I think guidelines would be helpful there, taking into account the sensitivity of the individual"
"(The) ways that the doctors come out and tell you. There have to be some guidelines that they need to go by in a situation like this"
"I think you reach a point where you can't read anymore and you can't search the internet anymore and you just need somebody to 
sit next to you and talk to you and explain things to you"
"That conversation regarding pancreatic cancer is never going to be a nice one and we have to avoid shooting the messenger there. 
Maybe there could be some protocol that specialists follow a little more thoroughly. No-one is ever going to want to hear it so it's 
never going to be well received"
Clinical communication
"I see a priority in education/awareness of pancreatic cancer because I've spoken to people who don't even know what it is or where 
it is"
"People have got to know what pancreatic cancer is and what some of the symptoms are, and I think we all acknowledge they are 
very vague, but the sharpening of that focus on "this could be" or "you need to". It's only when we know about something that we'll 
follow up on it"
"Pancreatic cancer may have been very familiar for an oncologist, but for the individual it isn't"
"When my mum's diagnosis came out, I was very much in the dark. I didn't get any information"
Public awareness
"When my father was diagnosed, we had some trouble making a decision about whether to just go with chemotherapy or the 
surgical option. We were having difficulty trying to ascertain which the best way to go was and we couldn't find a lot of information 
on what had a better outcome or did surgery exacerbate things? So this was another issue that came up with our family... treatment 
options"
"Less painful and distressing treatment"
"I know everything is hypothetical, but you have your operation and go through all of that, but there are really not enough options for 
you to make decisions about what you will or won't do"
Treatment optionsBMC Research Notes 2009, 2:179 http://www.biomedcentral.com/1756-0500/2/179
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Study Strengths and Limitations
To guarantee an accurate summary of the group discus-
sion and give an assurance that meaning had been cor-
rectly captured, all topics raised were summarised during
the discussions to give participants an opportunity to
immediately confirm or alter. This approach adds strength
to the study's internal reliability and validity.
While the qualitative methodology used in this study is
likely to be the most appropriate to gather information
from this highly vulnerable group where there are only
small numbers available to participate in research at any
one time, it has several limitations. The primary study lim-
itation is related to the small number of participants and
the convenience nature of the sampling strategy which sig-
nificantly limits the ability to broadly generalise the find-
ings. Furthermore, the small sample size could mean that
the full breadth of concerns of PC consumers may not
have been adequately captured. There is a critical need for
additional research to further validate both our findings
and the utility of a telephone-based approach to focussed
discussions.
Discussion
The ethical and practical issues of inquiries with people
with advanced cancer need to be carefully planned and
appropriate safeguards implemented. Facilitated tele-
phone discussion groups supported by trained counsel-
lors allowed us to reliably and suitably canvass the views
of a highly vulnerable consumer group. The approach
provided PC patients and carers the opportunity to
become involved in the research priority-setting process in
a manner that created minimal disruption to their lives,
and took into account varying levels of pain, mobility and
psychological distress. It was a welcomed opportunity for
these groups to express their needs in terms of research.
One of the difficulties of engaging PC consumers in
research is the relatively short time between disease diag-
nosis and death. Time-economy was a fundamental con-
sideration in the planning and implementation of the
current research. PC develops and spreads silently, and
closes in swiftly. Engaging with people who suffer from
this highly lethal, time limited disease is challenging as
there is often only a small window of opportunity availa-
ble. Capturing those affected early via established mecha-
nisms such as targeted projects, patient advice lines or
clinician referrals are likely to be the best avenues to pro-
vide those interested with the opportunity for research
involvement.
Research areas perceived by consumers to aid progress in
PC research in Australia have been identified via discreet
focussed discussions. Based on the direct experiences of
PC consumers, five themes have been identified as being
important subjects for further research. Early detection,
clinician communication, public awareness, quality of
care and improved treatment options are concluded to be
priorities for improving wellbeing and survival in PC. The
lack of existing similar investigations indicates the diffi-
culty of the task of sampling and investigating the priori-
ties held by PC consumers.
A common criticism of consumer involvement in expert
domains is the potential to obtain individual extreme per-
spectives. While we found clear areas of accordance and
difference between the priorities of PC consumers and
researchers, the identified consumer priorities are not
beyond the realms of reality or action; this supports the
growing argument for more involvement of consumers in
health and medical research generally.
We found general agreement between the research priori-
ties of consumers and those of researchers who took part
in our consensus process in the areas of early detection,
quality of care and the need to identify optimal treat-
ments. Priority areas that differed between the two groups
included the identification of prognostic markers; the
most common disease and treatment related sequelae of
PC on patients and their carers and strategies for manag-
ing them; patient-doctor communication and consumer
information on pancreatic cancer.
The importance of early diagnosis and more effective
treatment for pancreatic cancer, including options for
defining patients at high risk of pancreatic cancer, and
developing methods for detecting pancreatic tumours at
an early stage is starting to receive increasing attention
from a number of researchers globally [20-22] although it
lags well behind similar research on other cancer types
such as breast cancer. In addition, there is a growing but
relatively early focus on the biology of PC which is hoped
will lead to multiple potential therapeutic options by
directing treatment at these new biologic targets [23,24].
Sensitive information is normally conveyed to patients
and carers by clinicians through verbal communication.
Just how this is done varies considerably from clinician to
clinician [22]. The general need for further research into
the best methods for communicating serious health prob-
lems effectively and respectfully has been recognised by
some researchers, although effective solutions and note-
worthy improvements remain elusive [26-28]. Guidelines
for effectively communicating bad news to cancer patients
have been developed and widely distributed to oncolo-
gists [29,30]. However, a review of the effectiveness of
these guidelines has found that they may not reflect the
complexities of patient-oncologist interactions [31].
Other studies have found that the ability of the cancer
patient to recall what the oncologist has said is influencedBMC Research Notes 2009, 2:179 http://www.biomedcentral.com/1756-0500/2/179
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by prognosis, with patients with a poorer prognosis recall-
ing significantly less [32]. The findings of poor patient
acceptability, didactic approach and lack of wider family
communication have led to a recent inquiry to call for an
urgent revision of existing terminal prognosis communi-
cation protocols and practices taught in medical school
training [33].
More widespread and easily accessed public information
on pancreatic cancer has been recognised by a handful of
existing overseas patient support organisations [34,35] as
critical in raising awareness of possible symptoms, provid-
ing a reliable avenue for accurate and current treatment
and management information, and linking people to
answers and others affected by the disease. Unlike studies
that exist for many other cancer types [36-39] we could
find no formal inquiry investigating the best approaches,
true level of availability and effect of relevant information
resources on PC consumers.
The growing impetus to better address PC, including the
results of this first consumer inquiry, may help increase
focus by, and pressure on, health and medical research
funding organisations to further discriminate in favour of
this under prioritised and underfunded health problem.
Conclusion
This research gives us the first understanding of the role
that consumers with a known limited life expectancy can
play in identifying research that is responsive to commu-
nity needs and priorities when suitably planned and
implemented. Research has traditionally been controlled
by scientists to the exclusion of a societal perspective.
Investigating the issues faced by PC patients and carers
goes a long way towards understanding how science
might best 'fit' with their needs, contexts and expectations.
The research also provides a much better understanding of
the stark realities of the disease for those affected.
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